|
Characteristics
|
Valuesa (n = 49)
|
|---|
|
Age (yr)
|
11.5 (4–17)
|
|
Sex [females, n (%)]
|
33 (67.3 %)
|
|
Weight (kg)
|
41 (13.4–119.7)
|
|
Height (cm)
|
146 (95–178)
|
|
MTX weekly dose (mg)
|
13.75 (7.5–20)
|
|
MTX weekly dose (mg/kg)
|
0.31 (0.08–0.67)
|
|
MTX weekly dose (mg/m2)b
|
10.2 (4.1–15.5)
|
|
Number of medications prescribed
|
5 (1–8)
|
|
Number of side effects recorded
|
3 (1–2)
|
|
Pain scalec
|
0.9 (0–7.1)
|
|
General evaluation scalec
|
0.5 (0–8.2)
|
|
CMAS scored
|
51.5 (42–55)
|
-
aValues represent median (range), except where indicated otherwise
-
bSurface area was calculated using the Mosteller method [59]
-
cPain scale and general evaluation scores were obtained from the patients’ Childhood Health Assessment Questionnaire
-
dChildhood Myositis Assessment Scale (CMAS) score was recorded for children with JDM
